An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas

Human Pathology

Volumn 38, Issue 3, 2007, Pages 491-499

  DeHaan, Ryan D ^a   Kipp, Benjamin R ^a   Smyrk, Thomas C ^a   Abraham, Susan C ^a   Roberts, Lewis R ^b   Halling, Kevin C ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bile duct; Biliary tract; Dysplasia; FISH; Primary sclerosing cholangitis

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY DYSPLASIA; BILIARY TRACT DISEASE; CANCER INVASION; CENTROMERE; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCUS; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; MALE; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION;

ADULT; AGED; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED;

EID: 33846889537     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.09.004     Document Type: Article

References (30)

1. Rijken A.M., Hu J., Perlman E.J., et al. Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis. Genes Chromosomes Cancer 26 (1999) 185-191
2. Baron T.H., Harewood G.C., Rumalla A., et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2 (2004) 214-219
3. Abou-Rebyeh H., Al-Abadi H., Jonas S., Rotter I., Bechstein W.O., and Neuhaus P. DNA analysis of cholangiocarcinoma cells: prognostic and clinical importance. Cancer Detect Prev 26 (2002) 313-319
4. Lee J.Y., Park Y.N., Uhm K.O., Park S.Y., and Park S.H. Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization. J Korean Med Sci 19 (2004) 682-687
5. Koo S.H., Ihm C.H., Kwon K.C., Park J.W., Kim J.M., and Kong G. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet Cytogenet 130 (2001) 22-28
6. Wong N., Li L., Tsang K., Lai P.B., To K.F., and Johnson P.J. Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma. J Hepatol 37 (2002) 633-639
7. Chariyalertsak S., Khuhaprema T., Bhudisawasdi V., Sripa B., Wongkham S., and Petmitr S. Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. J Cancer Res Clin Oncol 131 (2005) 821-828
8. Kim D.G., Park S.Y., You K.R., et al. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding. Genes Chromosomes Cancer 30 (2001) 48-56
9. Tannapfel A., Sommerer F., Benicke M., et al. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J Pathol 197 (2002) 624-631
10. Caca K., Feisthammel J., Klee K., et al. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Int J Cancer 97 (2002) 481-488
11. Tannapfel A., Benicke M., Katalinic A., et al. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 47 (2000) 721-727
12. Liggett W., and Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16 (1998) 1197-1206
13. Hustinx S.R., Leoni L.M., Yeo C.J., et al. Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion. Mod Pathol 18 (2005) 959-963
14. Fahmy M., Skacel M., Gramlich T.L., et al. Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod Pathol 17 (2004) 588-596
15. Taniai M., Higuchi H., Burgart L.J., and Gores G.J. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology 123 (2002) 1090-1098
16. Yoshida S., Todoroki T., Ichikawa Y., et al. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55 (1995) 2756-2760
17. Ahrendt S.A., Eisenberger C.F., Yip L., et al. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. J Surg Res 84 (1999) 88-93
18. Burak K., Angulo P., Pasha T.M., Egan K., Petz J., and Lindor K.D. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99 (2004) 523-526
19. Kipp B.R., Stadheim L.M., Halling S.A., et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 99 (2004) 1675-1681
20. Qian J., Bostwick D.G., Takahashi S., et al. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 149 (1996) 1193-1199
21. Brunelli M., Eble J.N., Zhang S., Martignoni G., Delahunt B., and Cheng L. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 18 (2005) 161-169
22. Geradts J., Hruban R.H., Schutte M., Kern S.E., and Maynard R. Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies. Appl Immunohistochem Mol Morphol 8 (2000) 71-79
23. Ventura R.A., Martin-Subero J.I., Jones M., et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 8 (2006) 141-151
24. Wilkens L., Gerr H., Gadzicki D., Kreipe H., and Schlegelberger B. Standardised fluorescence in situ hybridisation in cytological and histological specimens. Virchows Arch 447 (2005) 586-592
25. Klump B., Hsieh C.J., Dette S., Holzmann K., Kiebetalich R., Jung M., et al. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease. Clin Cancer Res 9 (2003) 1773-1778
26. Moreno Luna L.E., Kipp B., Halling K.C., Sebo T.J., Kremers W.K., Roberts L.R., et al. Advanced cytologic techniques for the detection of malignant panceratobiliary strictures. Gastroenterology 131 (2006) 1064-1072
27. Gwak G.Y., Yoon J.H., Shin C.M., Ahn Y.H., Chung J.K., Kim Y.A., et al. Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholagiocarcinomas. J Cancer Res Clin Oncol 131 (2005) 649-652
28. Yoon J.H., Gwak G.Y., Lee H.S., Bronk S.F., Werneburg N.W., and Gores G.J. Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells. J Hepatol 41 (2004) 808-814
29. Fahmy M., Skacel M., Gramlich T.L., Brainard J.A., Rice T.W., Goldblum J.R., et al. Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod Pathol 17 (2004) 588-596
30. Rashid A. Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am 11 (2002) 995-1009